The management of squamous cell vulval cancer: A population based retrospective study of 411 cases

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 105, Issue 2, 1998, Pages 200-205

  Rhodes, Catharine A ^a   Cummins, Carole ^b   Shafi, Mahmood I ^c  

^a CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TREATMENT OUTCOME; UNITED STATES; VULVA CARCINOMA; VULVECTOMY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; ENGLAND; FEMALE; HUMANS; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VULVAR NEOPLASMS;

EID: 0031907849     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1998.tb10053.x     Document Type: Article

References (21)

1. Mack TM, Cozen W, Quinn MA. Epidemiology of cancer of theendometrium, ovary, vulva and vagina. In: Coppleson M, Monaghan JM, Morrow CP, Tattershall MH, editors. Gynaecological Oncology: Fundamental Principles and Clinical Practice. Edinburgh : Churchill Livingstone, 1992: 31–54.
2. OPCS. Cancer Statistics Registrations (England and Wales) Series MBI, No. 21. London : HMSO: 1994.
3. Taussig FJ. Cancer of the vulva: an analysis of 155 cases(1911–1940). Am J obstet Gynecol 1949; 40: 764–779.
4. Way S. Carcinoma of the vulva. Am J Obstet Gynecol 1960; 79: 692–697.
5. Farias-Eisner R, Berek JS. Current management of invasive squa-mouscarcinomaofthe vulva. Clin Geriatr Med 1993; 9: 1131–1143.
6. Cavanagh D, Hoffman MS. Controversies in the management of vul-var carcinoma. Br J Obstet Gynaecol 1996; 103: 293–300.
7. International Federation of Gynaecology and Obstetrics (FIGO). Changes in gynaecologic cancer staging by the International Fed cration of Gynaecology and Obstetrics. Am J Obstet Gynecol 1990; 162: 610–611.
8. Hopkins MP, Reid GC, Johnston CM, Morley GW. Acomparison ofstaging systems for squamous cell carcinoma of the vulva. Gynecol Oncol 1992; 47: 34–37.
9. Shanbour KA, Mannel, RS, Moms, PC, Yadack A, Walker JL. Corn-parison of clinical versus surgical staging systems in vulvar cancer. Obstet Gynecol 1992; 80: 927–930.
10. Shepherd J. Cervical and vulval cancer: changes in FIG0 definitionsof staging. Br J Obstet Gynaecol 1996; 103: 405–406.
11. A policy framework for commissioning cancer services. Guidance forpurchasers and providers of cancer services. Department of Health, May 1995.
12. The Royal College of Obstetricians and Gynaecologists, The British Gynaecological Cancer Society. A joint working group response to ‘Apolicy framework for commissioning cancer services’: Consultationdocument; August 1996.
13. Selby P. Hospital based cancer services: The relevance of spccialisedcare. In: A policy frame work for commissioning. Guidance for purchasers and providers of Cancer Services(AnnexB). London :Department of Health, 1995.
14. Van Der Velden J, Van Lindert ACM, Gimbrere CHF, Oosting H, Heintz PM. Epidemiological data on vulvar cancer: comparison ofhospital with population-based data. Gynecol Oncol 1996; 62:379–383.
15. Kelley JL, Burke TW, Tornos C et al. Minimally invasive vulvar carcinoma: an indication for conservative surgical therapy. Gynecoloncol 1992; 44: 240–244.
16. Keys H. Gynecology Oncology Group randomised trials of combinedtechnique therapy for vulvar cancer. Cancer 1993; 71: 1691–1696.
17. Stehman FB, Bundy BN, Dvoretsky PM, Creasinan WT. Early stage Icarcinoma of the vulva treated with ipsilateral superficial inguinallymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol 1992; 79:490–497.
18. Pettersson F, Creasman WT, Shepherd JH, Pecorelli S, editors. Annual Report on the Results of Treatment in Gynaecological Cancer, Vol 22. Stockholm, Sweden : International Federation of Gynecologyand Obstetrics, 1995.
19. Miller B, Morris M, Levenback C, Burke TW, Gershenson DM. Pelvic exenteration for primary and recurrent vulvar cancer. Gynecoloncol 1995; 58: 202–205.
20. Piura B, Masotina A, Murdocb J, Lopes A, Morgan P, Monaghan I.Recurrent squamous cell carcinoma of the vulva: a study of 73 cases. Gynecol Oncol 1993; 48: 189–195.
21. Homesley HD, Bundy BN, Sedlis A et al. Assessment of current Inter-national Federation of Gynecology and Obstetrics staging of vulvarcarcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol 1991; 164: 997–1003.